Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix and Prevenar 13 Primary and Booster Vaccination in Infants
NCT01641133Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2012
- Primary completion
- Jul 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Sep 2012; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01641133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641133.